Skip to main content

Table 2 FFA profiles of healthy controls and NAFLD patients*

From: Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case – control study

 

HC (n = 66)

NAFLD Patients

FFA (μg/ml)

Lean (n = 67)

Overweight (n = 55)

Obese (n = 48)

14:0

5.00 ± 2.49

7.65 ± 3.25a

7.13 ± 4.74a

11.23 ± 8.14a b c

16:0

431.38 ± 102.97

495.62 ± 100.32a

478.25 ± 119.66

571.50 ± 190.60a b c

16:1

29.52 ± 13.56

42.65 ± 16.93a

44.21 ± 28.85a

54.49 ± 30.27a b c

18:0

165.75 ± 49.83

200.46 ± 57.69a

193.95 ± 53.61a

206.68 ± 59.56a

18:1

240.53 ± 92.15

286.83 ± 65.19a

293.28 ± 103.12a

346.61 ± 118.96a b c

18:2

817.38 ± 266.00

898.36 ± 179.39a

880.29 ± 146.17

942.46 ± 202.84a

18:3

33.49 ± 12.62

46.54 ± 23.59a

49.87 ± 24.93a

50.09 ± 26.22a

γ-18:3

13.40 ± 7.15

22.20 ± 10.92a

20.43 ± 12.66a

20.30 ± 11.48a

20:4

142.71 ± 39.80

164.67 ± 42.92a

162.05 ± 46.79

158.19 ± 68.43

20:5

9.74 ± 8.54

12.43 ± 5.61

16.90 ± 32.62

21.33 ± 31.26a

22:5

5.38 ± 2.45

8.38 ± 4.67a

9.28 ± 7.17a

10.42 ± 3.99a

22:6

179.32 ± 61.94

223.62 ± 65.28a

222.52 ± 61.41a

257.80 ± 133.98a b

Total FFA

2093.33 ± 558.11

2426.09 ± 465.28a

2420.81 ± 555.18a

2739.01 ± 810.35a b c

  1. *All P-values were tested using ANCOVA and Bonferroni post – hoc test adjusting for sex and age
  2. a P < 0.05, when compared with healthy controls;
  3. b P < 0.05, when compared with lean – NAFLD group;
  4. c P < 0.05, when compared with overweight – NAFLD group